Introduction
Systemic lupus erythematosus (SLE) commonly involves the kidney, which is known as lupus nephritis (1) . The clinical manifestations of lupus nephritis, which vary from no or mild urinary abnormalities to severe renal insufficiency, are thought to correlate generally with the severity and histological type of glomerular lesions. The various forms of lupus nephritis are, therefore, classified following recommendations of the World Health Organization (WHO) and International Society of Nephrology (ISN) (1, 2) . Vascular lesions are not uncommon in lupus nephritis, and their presence can affect the prognosis of the renal disease (3, 4) ; the assessment of vascular lesions, however, is not described fully in the WHO/ISN classification (1, 2) . Glomerular pathological changes are emphasized and vascular lesions are sometimes overlooked.
Here, we describe a SLE patient who presented with onset of hypertension associated with multiple renal infarctions and interstitial lesions, which were caused by renal lupus vasculopathy, one of the vascular lesions that occur in lupus nephritis (3, 4) .
Case Report
In December 2004, a 30-year-old woman with a 10-year history of SLE was admitted to our hospital because of the onset of hypertension. In 1995, she had developed facial erythema and arthralgia with a high titer of antinuclear antibody (ANA) and anti-double stranded DNA (ds-DNA) antibody, and was diagnosed as having SLE, and had started steroid therapy. In September 1999, she had developed central nervous system (CNS) lupus and digital gangrene. Intravenous pulse-steroid therapy and resection of thoracic sympathetic ganglia had improved her symptoms. In May 2003, she presented with a flare-up of SLE with nystagmus and right hemiplegia. Magnetic resonance imaging of brain did not show any abnormal findings, but single-photon emission computed tomography revealed decreased blood flow in the cerebrum, which were consistent with findings of CNS lupus. Increased dose of oral steroid following intravenous pulse-steroid therapy induced the clinical improvement of nystagmus and right hemiplegia. Physical therapy was required for right hemiplegia. Anti-cardiolipin antibodies or lupus anticoagulants had not been identified, nor had she been noted to have hypertension, renal dysfunction, or urinary abnormalities. In September 2004, she was treated with prednisolone at 5 mg per day, and did not have any symptoms, except right hemiplegia, or signs of recurrence of SLE. In October 2004, she was noted to have hypertension (160/100 mmHg) with increased activity of plasma renin (10 ng/ml/hour) and marked proteinuria (0.8 g per day), and she was treated with the angiotensin-receptor-blocker (ARB): Losartan potassium at 25 mg per day.
On admission, the patient was comfortable, and her blood pressure was 128/78 mmHg. No new skin lesions were found. No physical abnormalities were identified except right hemiplegia. Laboratory findings on admission are shown in Tables 1 and 2 . Serum creatinine was slightly increased, 24-hour creatinine clearance was 55.7 ml per minute, and her urine showed normal urinalysis and bland urine sediments with 0.1 g daily protein excretion. Mild thrombocytopenia was found, but lactate dehydrogenase level, and peripheral blood analysis and smear, the level of haptoglobin were normal. Coagulation screen and liver biochemistry results were normal. Mild hypocomplementemia had been persisting from1999. Tests for hepatitis B and hepatitis C, ds-DNA antibodies, anti-cardiolipin antibodies (anti-2-glycoprotein I antibody, IgG isotype), lupus anticoagulants detected with dilute activated partial prothromboplastin time and dilution Russell viper venom time, and antineutrophil cytoplasmic antibodies (ANCA) were negative. Based on these findings, we considered it likely that she had renovascular hypertension. Contrast-enhanced computed tomography (CT) scan revealed multiple defects in the bilateral kidneys (Fig. 1A) , indicating renal infarction. Moreover, renal arteriography showed no stenosis in main arteries, but multiple defects were observed on nephrogram, and arterial cut-off or tapering stenosis was present in the interlobular arteries (Fig. 1B) . General view of renal biopsy showed severely atrophic tubules, severe mononuclear cell interstitial infiltration, and interstitial fibrosis ( Fig. 2A) . Global sclerosis was seen in two out of the 26 glomeruli examined. Mild glomerular cell proliferation was found, but glomerular tuft necrosis and crescent formations were not found. Glomerular basement membranes were wrinkled with mesangiolysis in some glomeruli ( Fig. 2A) , indicating ischemic glomerular changes. Concentric intimal thickening with periodic acidSchiff-positive homogenous material was also found in some arterioles ( Fig. 2B ) and the lumen of an arteriole was narrowed or occluded by eosinophilic material (Fig. 2C, D) . No inflammatory vascular lesion showing leukocyte infiltration was found. Immunofluorescence microscopy revealed no staining for IgG/IgA/IgM/C3/C4 or C1q throughout glomerular capillaries. The deposition of IgG/IgM/C3, but not IgA/C4 or fibrinogen, was found in the wall of an arteriole and a small artery (Fig. 2E) . These results indicate that these vascular lesions might have caused the ischemic changes in the kidney, such as renal infarction, interstitial lesions, and later onset of high-renin hypertension. As her blood pressure was controlled well with the ARB and renal function was stable, she was discharged.
Discussion
In this case, we note the following observations: 1) The contrast-enhanced CT and renal arteriography revealed multiple renal infarctions and arterial cut-off or tapering stenosis in the interlobular arteries of the kidney; 2) The renal biopsy specimen showed concentric intimal thickening with the narrowed or occluded lumen in some arterioles without active inflammatory changes and deposition of IgG/IgM/C3 in the wall of arteriole; 3) No active lesions or immune complex deposition were identified in glomeruli; 4) Severely atrophic tubules, severe mononuclear cell interstitial infiltration, and interstitial fibrosis were found. These findings indicate that the present patient had vascular lesions in the arterioles and the interlobular arteries of the kidney.
Vascular lesions are commonly found in renal biopsy specimens from patients with lupus nephritis (3, 4). Klemperer described a high incidence of renal vascular lesions in autopsies of SLE patients in 1941, but glomerular lesions were subsequently emphasized as the WHO classification (1) . The importance of the association between renal vascular lesions and lupus nephritis has recently been reconsidered (3, 4) . Five different types of vascular lesions have been identified in lupus nephritis: uncomplicated vascular immune deposits, lupus vasculopathy (so-called non-inflammatory necrotizing vasculopathy), thrombotic microangiopathy (TMA), arteriosclerosis and arteriolosclerosis, and necrotizing vasculitis [polyarteritis nodosa (PAN)] (3, 4) .
Uncomplicated vascular immune deposits are the most common renal vascular lesions in SLE. The affected vessels usually appear normal by light microscopy and the vessel lumen is not compromised (3, 4) . Lupus vasculopathy (3, 4) , also called non-inflammatory necrotizing vasculopathy, predominantly affects pre-glomerular arterioles, and to a lesser extent, it affects interlobular arteries. This lesion is characterized by narrowing or occlusion of vessels by necrotizing vascular changes without inflammation, and by the deposition of immune complex in vascular walls; thus it is thought to be caused by an immune-mediated process. TMA shows pathological and clinical manifestation similar to lupus vasculopathy (3) (4) (5) . TMA is usually associated with antiphospholipid syndrome (6) or hemolytic-uremic syndrome (HUS)/thrombotic thrombocytopenic purpura (TTP) in SLE patients (3, 4) . In contrast to lupus vasculopathy, TMA is thought to be a non-immune and non-inflammatory vasculopathy and does not show the deposition of immune complex, particularly IgG, on vascular walls (3, 4). Our patient was not found to have anti-phospholipid antibodies, lupus anticoagulants, severe thrombocytopenia, hemolytic anemia, the clinical manifestations of HUS/TTP, or arteriolar and/or arterial thrombosis in her renal biopsy specimen, suggesting her renal vascular lesions are not likely to be TMA. Arteriosclerosis or arteriolosclerosis may cause the similar vascular lesions, but in our case the deposition of IgG was identified in the renal arteriole. As IgG is not nonspecifically trapped in vessels with the ordinary arteriosclerosis or arteriolosclerosis (4), an immune-mediated process might be involved in the pathogenesis of vascular lesions in our case. Although necrotizing changes in the vessel wall were not found, the renal biopsy showed concentric intimal thickening with the narrowed or occluded lumen in some arterioles without active inflammatory changes, and deposition of IgG/IgM/C3 in the wall of arteriole, indicating the vascular lesion in our patient is most likely lupus vasculopathy.
The renal arteriography for our patient showed similar abnormal findings as PAN, such as multiple perfusion defects on nephrogram, and arterial cut-off or tapering stenosis (7) . The true inflammatory necrotizing vasculitis is the least common among the renal vascular lesions occurring in SLE (3). Further, our patient did not show any typical clinical manifestations of vasculitis, such as weight loss, fever, or laboratory findings of inflammation, and the necrotizing vasculitis of renal arteries was not identified in the renal biopsy specimen. Based on these findings and clinical symptoms, we diagnosed her as having lupus vasculopathy, which caused the renal ischemic changes, such as multiple renal infarctions, interstitial lesions, and high-renin hypertension controlled with ARB.
Lupus vasculopathy has been reported to be generally associated with the most severe and active forms of diffuse proliferative lupus nephritis (WHO class IV); thus its clinical manifestations are severe renal function impairment, active urinary sediments, active lupus serologies, severe hypertension, and rapid progression to renal failure (3, 4, (8) (9) (10) . Our patient, however, showed no active urinary abnormalities, severe or active glomerular lesions, or active lupus clinical manifestations. There is a possibility that the long-term steroid therapy might modulate the glomerular pathological changes and cause mild urinary abnormalities in our case. Takazoe et al have reported a similar case of SLE which was accompanied by renal dysfunction and vascular immune deposits in the kidney without active urinary findings or active glomerular lesions (11) .
In the present case, the renal ischemic changes, such as multiple renal infarctions, progressed insidiously, resulting in the loss of almost a quarter of the renal parenchyma. Renal infarction has been reported to develop in SLE patients with positive anti-phospholipid antibodies or lupus anticoagulant (12, 13) . To our knowledge, ours is the first case of lupus vasculopathy causing renal infarction in a SLE patient.
The treatment of lupus vasculopathy has not been established. As it is almost invariably associated with active lupus glomerular lesions, aggressive immunosuppressive or plasmapheresis therapies have been applied (8, 9) . Descombes et al have reported that lupus vasculopathy may reverse with immunosuppressive therapy (10) . Our patient showed neither active inflammatory lesions in the renal biopsy specimen nor severe inflammatory laboratory findings; thus the aggressive immunosuppressive therapies may not be necessary and may even be harmful. There is, however, a possibility that the intensive steroid therapy for the last flare-up of CNS lupus might modulate the progression of renal vascular lesions in our case. We think anti-platelet or anti-coagulation therapy might prevent further progression of the renal ischemic changes in our case like the therapy for antiphospholipid syndrome nephropathy (6) and close clinical follow-up is necessary.
In summary we present a case of lupus vasculopathy accompanied by renal infarction without active glomerular lesions. More attention needs to be paid to the renal vascular lesions occurring in SLE because these lesions may be one of the prognostic factors for the loss of renal function in lupus nephritis.
